Nature Reviews Drug Discovery 16, 589–591 (2017)
On page 589 of the above article, the position of Steve Jackson was incorrectly stated as CEO of Mission Therapeutics, rather than CSO. The error has been corrected in the html and pdf versions online.
Additional information
The online version of the original article can be found at 10.1038/nrd.2017.165
Rights and permissions
About this article
Cite this article
Mullard, A. Erratum: Synthetic lethality screens point the way to new cancer drug targets. Nat Rev Drug Discov 16, 736 (2017). https://doi.org/10.1038/nrd.2017.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.189
This article is cited by
-
Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility
Nature Communications (2020)
